Literature DB >> 8778168

Improvement of upper airway obstruction after 131I-treatment of multinodular nontoxic goiter evaluated by flow volume loop curves.

B Nygaard1, U Søes-Petersen, P F Høilund-Carlsen, A Veje, P E Holst, A Vestergaard, K Sølling.   

Abstract

Symptoms of tracheal-esophageal compression are often related to a large nontoxic goiter. The aim of the present study was to evaluate to what degree upper airway obstruction, as measured by flow volume loops, FIF50% and FEF50%/FIF50% (Forced Expiratory Flow at 50% of the vital capacity/ Forced Inspiratory Flow at 50% of the vital capacity) exists in nontoxic multinodular goiter, and whether changes occur after 131I-treatment. Thirteen patients with large multinodular nontoxic goiters were evaluated by estimation of FIF50%, FEF50%/FIF50% ratio and a graphic plot of the flow volume loop curve before and three, six and 12 months after treatment with 131I. FIF50% increased over 12 months from median 1.79 l/sec (range 1.46-3.02) to 2.84 l/sec (1.13-5.69) (p = 0.01). A progressive increase was seen over time (p = 0.001, trend analysis). The FEF50%/FIF50% ratio decreased from in 1.45 (0.32-2.26) to 1.03 (0.43-2.13) 12 months after treatment (p < 0.001). A progressive decrease was seen over time (p = 0.001, trend analysis). By visual evaluation 11 had a flow volume loop curve typical for an upper airway obstruction and in 9 patients the FEF50%/FIF50% ratio was > 1.2. In conclusion we found that upper airway obstruction is present in patients with multinodular nontoxic goiter, and seems to be reduced after 131I-treatment. Flow volume loop curves and measurement of FEF50% and FIF50% are important estimates for upper airway obstruction in these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8778168     DOI: 10.1007/bf03349839

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  [RESULTS OF RADIOIODINE REDUCTION THERAPY OF EUTHYROID GOITER].

Authors:  W KEIDERLING; D EMRICH; C HAUSWALDT; G HOFFMANN
Journal:  Dtsch Med Wochenschr       Date:  1964-03-06       Impact factor: 0.628

2.  Flow volume loops in patients with goiters.

Authors:  J G Geraghty; E C Coveney; M Kiernan; N J O'Higgins
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

3.  Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre.

Authors:  L Hegedüs; B M Hansen; N Knudsen; J M Hansen
Journal:  BMJ       Date:  1988-09-10

4.  Standardization of spirometry--1987 update. Statement of the American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1987-11

5.  Evaluation of obstructing lesions of the trachea and larynx by flow-volume loops.

Authors:  R D Miller; R E Hyatt
Journal:  Am Rev Respir Dis       Date:  1973-09

6.  The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects.

Authors:  L Hegedüs; H Perrild; L R Poulsen; J R Andersen; B Holm; P Schnohr; G Jensen; J M Hansen
Journal:  J Clin Endocrinol Metab       Date:  1983-02       Impact factor: 5.958

7.  Upper airway obstruction in euthyroid goiter.

Authors:  R Jauregui; E S Lilker; A Bayley
Journal:  JAMA       Date:  1977-11-14       Impact factor: 56.272

8.  Radioiodine treatment of multinodular non-toxic goitre.

Authors:  B Nygaard; L Hegedüs; M Gervil; H Hjalgrim; P Søe-Jensen; J M Hansen
Journal:  BMJ       Date:  1993-10-02

9.  Large, compressive goiters treated with radioiodine.

Authors:  D A Huysmans; A R Hermus; F H Corstens; J O Barentsz; P W Kloppenborg
Journal:  Ann Intern Med       Date:  1994-11-15       Impact factor: 25.391

10.  Tracheal or esophageal compression due to benign thyroid disease.

Authors:  A Alfonso; G Christoudias; Q Amaruddin; H Herbsman; B Gardner
Journal:  Am J Surg       Date:  1981-09       Impact factor: 2.565

View more
  1 in total

1.  Radioiodine treatment for non-toxic goitre.

Authors:  Ulla Feldt-Rasmussen
Journal:  F1000 Med Rep       Date:  2009-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.